Generation of histocompatible tissues using nuclear transplantation

Area of Science:

• Regenerative Medicine
• Transplantation Biology
• Cellular Reprogramming

Background:

• Nuclear transplantation (therapeutic cloning) offers a potential source of patient-specific cells for regenerative therapy.
• Mitochondrial DNA (mtDNA) differences between donor nucleus and recipient oocyte raise concerns about histocompatibility of cloned cells.
• Generating histocompatible cells is crucial for successful transplantation.

Purpose of the Study:

• To create and assess the viability and function of bioengineered tissues derived from cloned cells.
• To investigate the histocompatibility and potential for immune rejection of cloned tissues.
• To demonstrate the therapeutic potential of nuclear transplantation for regenerative medicine.

Main Methods:

• Nuclear transplantation using adult bovine fibroblasts to create cloned cells.
• Development of bioengineered cardiac, skeletal muscle, and renal tissues from cloned cells.
• Assessment of tissue viability, function, and gene/protein expression using RT-PCR, Western blot, and in vivo/in vitro immunological assays (DTH, Elispot).

Main Results:

• Cloned tissues (cardiac, skeletal muscle, renal) demonstrated long-term viability after transplantation into nuclear donor animals.
• Cloned tissues expressed tissue-specific mRNA and proteins but possessed a different mtDNA haplotype.
• Engineered renal units produced urine-like fluid, concentrated waste products, and formed organized glomeruli- and tubule-like structures without signs of immune rejection.

Conclusions:

• Nuclear transplantation can generate functional, histocompatible tissues for regenerative therapy.
• The study successfully created bioengineered tissues, including functioning renal units, from cloned cells.
• The absence of rejection responses suggests therapeutic cloning can overcome major hurdles in transplantation medicine.